Moody's Corporation (MCO) Stock Price Today
Aura AI Summary
Key Stats
- $83.85BMarket Cap
- -Volume
- FinancialsSector
- $539.6152W High
- $412.2352W Low
- -Typical Hold Time
- $89.88BEnterprise Value
- 0.85%Div Yield
- -Trading Activity
Track Moody's Corporation (MCO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Moody's Corporation has traded between a low of $412.23 and a high of $539.61, highlighting its annual price range. Buy and sell Moody's Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities. Moody's ratings segment, known as Moody's Investors Service or MIS, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's revenue and profits. Moody's other segment is Moody's Analytics and consists of Research, Data, and Analytics or RD&A and Enterprise Risk Solutions or ERS. RD&A's products include credit research, quantitative credit scores, economic research, business intelligence, know your customer (KYC) tools, commercial real estate data and analytical tools, and training services. ERS includes risk management software solutions to financial institutions.
Most Recent News
Altisource CEO buys shares amid 19% revenue rise and AI-driven efficiency boost
Altisource Portfolio Solutions' CEO Shepro William B purchased 4,000 shares, increasing his stake to 8,686 shares, signaling confidence in the company's future. The company reported a 19% year-over-year increase in Q2 2026 service revenue to $48.70 m...

Access barriers limit Xphozah uptake despite nephrologists' willingness to triple use, with reimbursement changes ahead.
New research from Spherix Global Insights reveals that access barriers, not drug efficacy, restrict the use of Ardelyx's Xphozah for dialysis patients with hyperphosphatemia. Nephrologists say they would nearly triple Xphozah prescriptions if reimbur...

Plug Power stock surged 83% early 2026 but lost all gains by midyear, raising questions on its outlook.
Plug Power's stock price jumped 83% in the first five months of 2026, reflecting strong investor enthusiasm for hydrogen energy. However, by midyear, the stock gave back all those gains, returning to its earlier levels. This volatility highlights the...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.